Lista de obras -

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer

artículo científico publicado en 2017

A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number

artículo científico publicado en 2010

Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours

artículo científico publicado en 2014

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

artículo científico publicado en 2017

Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.

artículo científico publicado en 2016

Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib

artículo científico publicado en 2012

Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

artículo científico publicado en 2012

Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours

artículo científico publicado en 2011

Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors

artículo científico publicado en 2014

Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.

artículo científico publicado en 2014

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

artículo científico publicado en 2015

Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumours.

artículo científico publicado en 2012

Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.

artículo científico publicado en 2009

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

artículo científico publicado en 2014

Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up

artículo científico publicado en 2011

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

artículo científico publicado en 2018

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2017

Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.

artículo científico publicado en 2014

Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes

artículo científico publicado en 2010

Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review).

scientific article published on June 2009

Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)

artículo científico publicado en 2015

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.

artículo científico publicado en 2016

Psychosocial Issues in Long-Term Survivors of Testicular Cancer

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 201

artículo científico publicado en 2016

Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor

artículo científico publicado en 2011

Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report

artículo científico publicado en 2012

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

artículo científico publicado en 2016

Systemic immune-inflammation index to predict the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

Taxane-related nail toxicity.

artículo científico publicado en 2015

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

artículo científico publicado en 2018

Three cases of bone metastases in patients with gastrointestinal stromal tumors

artículo científico publicado en 2011

Lista de obras de

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer

A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number

Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours

Association among metabolic syndrome, inflammation, and survival in prostate cancer

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.

Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib

Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours

Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors

Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumours.

Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.

Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes

Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review).

Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.

Psychosocial Issues in Long-Term Survivors of Testicular Cancer

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 201

Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor

Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

Systemic immune-inflammation index to predict the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

Taxane-related nail toxicity.

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Three cases of bone metastases in patients with gastrointestinal stromal tumors

Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma